🕵️ Ingevity Corp ($NGVT)
SEC insider & ownership activity, last 12 months · CIK 1653477 · every row links its SEC filing
Over the last 12 months insiders sold $1.8M with no open-market buying against it. David H. Li sold $1.5M through a 10b5-1 trading plan in 5 lots (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $1.8M (10 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| David H. Li | 0 | – | 5 | $1.5M | Aug 18, 2026 |
| Ryan C. Fisher | 0 | – | 2 | $200K | Aug 3, 2026 |
| Terrance M. Dyer | 0 | – | 3 | $34K | May 28, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15.5% | 13G | Apr 30, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 6.3% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| David H. Li | $1.6M | Aug 12, 2026 | filing ↗ |
| Ryan C. Fisher | $200K | Aug 3, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 26, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 1, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jan 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |